Repligen Corporation (RGEN) Earnings Call Analysis
NASDAQ · Healthcare · Medical Instruments & Supplies
Earnings Reports
-
Repligen (RGEN) Q2 2026: Protein Franchise Soars 50%, Margin Expansion Accelerates Strategic Shift
July 28, 2026
-
Repligen (RGEN) Q1 2026: Analytics Surges 50%, Margin Expansion Accelerates Transformation
May 05, 2026
-
Repligen (RGEN) Q4 2025: Analytics Grows 37%, Multi-Year Upgrade Cycle Accelerates Margin Upside
February 25, 2026
-
Repligen (RGEN) Q3 2025: Analytics Franchise Surges 50%, Driving Portfolio Diversification Momentum
October 28, 2025
-
Repligen (RGEN) Q2 2025: Chromatography Revenue Surges 40%, Outpacing Bioprocessing Market Growth
July 29, 2025
-
Repligen (RGEN) Q1 2025: Non-COVID Organic Growth Hits 14% as Order Funnel Expands 30%
July 07, 2025